INTRODUCTION
DNA-dependent protein kinase catalytic subunits (DNA-PKcs) are critical components of the nonhomologous end-joining (NHEJ) pathway of the DNA double-strand break (DSB) repair system. DSBs are usually generated by environmental influences such as ionizing radiation (IR) or by chemical mutagens, or are created during programmed processes such as V(D)J recombination or class switch recombination (CSR), which occur during lymphocyte development (Franco et al., 2006; Mahaney et al., 2009; Shrivastav et al., 2008; Yan et al., 2007) . The Ku70/80 heterodimer first binds to the ends of the DSBs and recruits DNAPKcs to form the active DNA-PK complex. Subsequently, together with Artimis, DNA-PKcs stimulate the processing of the DNA ends. Finally, the LIG4 complex, comprising LIG4, XRCC4, and XLF, seals the DSBs generated during NHEJ. Humans and several types of mammals with a defect in the genes involved in NHEJ cannot complete V(D)J recombination. This blocks lymphocyte development, resulting in severe combined immunodeficiency (SCID) (Bosma et al., 1983; O'Driscoll and Jeggo, 2006; Perryman, 2004; van der Burg et al., 2009) . SCID mice, which arose spontaneously due to the defective DNA-PKcs gene (Prkdc), show an immunodeficient phenotype and increased sensitivity to IR (Bosma et al., 1983) . In contrast, no PRKDC mutations had been reported in humans until recently, when a hypomorphic mutation with PRKDC kinase activity was identified in a patient with SCID with sensitivity to IR (RS-SCID; van der Burg et al., 2009) . Although complete PRKDC deficiency is expected to be lethal in humans, spontaneous null mutations in the PRKDC gene were reported in Arabian horses and Jack Russell terriers, highlighting the fact that PRKDC deficiency is not tolerated equally in all species (Perryman, 2004) .
SCID animals are widely used in biomedical research as hosts for allogeneic and xenogeneic tissue grafts. Humanized mice (i.e., immunodeficient mice engrafted with human cells or tissues, such as human hematopoietic stem cells [hHSCs] , hepatocytes, or tumor cells) are powerful tools that have enabled scientists to gain greater insights into many human diseases (Azuma et al., 2007; Baiocchi et al., 2010; Brehm et al., 2010; Denton and García, 2011; Ito et al., 2008; Katoh et al., 2008; Kneteman and Mercer, 2005; Leonard, 2001; Meuleman et al., 2005; Pearson et al., 2008; Quintana et al., 2008; Shultz et al., 2007; Wege et al., 2008) . Although the laboratory rat is an ideal model for physiological, pharmacological, toxicological, and transplantation studies, there are no reports of spontaneous, or gene-targeted, SCID rats. Recently, several strategies have been developed to produce a wide variety of genomic alterations in rats (Geurts et al., 2009; Izsvá k et al., 2010; Mashimo et al., 2008; Tesson et al., 2011) , including embryonic-stem-cellderived p53 knockout rats (Tong et al., 2010) . Other investigators and our group have also shown the successful application of zinc-finger nucleases (ZFNs) as a gene-targeting technology in rats, which is faster and more efficient than embryonic-stem- cell-mediated knockout technology (Cui et al., 2011; Geurts et al., 2009; Mashimo et al., 2010) .
Here, we report the generation and characterization of single-knockout Prkdc (SCID) and double-knockout Prkdc and Il2rg (F344-scid gamma [FSG] ) rats.
RESULTS

Generation of SCID Rats Using ZFNs
The design and validation of ZFN reagents targeting the first exon of rat Prkdc gene were described previously (Mashimo et al., 2010) (Figure 1A; Figure S1) . The validated ZFN mRNA was microinjected into fertilized F344/Stm or Crlj:WI oocytes, which were then transferred into the oviducts of pseudopregnant Crlj:WI female rats ( Figure 1B) . Screening of 39 newborn animals revealed that 26 of them (66.7%) carried mutations, comprising deletions from 1 bp to 919 bp and a 1-bp insertion (Figures 1C and 1D ; Figure S2 ). The rate and variation of the ZFN-induced mutations were similar to those reported in previous studies (Cui et al., 2011; Geurts et al., 2009; Mashimo et al., 2010) . The majority of these were frame-shift mutations resulting in the complete loss of mRNA expression as confirmed by reverse transcriptase (RT)-PCR ( Figure 1E ) and protein expression as confirmed by western blotting ( Figure 1F ). Furthermore, double injection of Prkdc and interleukin 2 receptor-gamma (Il2rg) ZFN-encoding mRNA into 219 fertilized F344/Stm oocytes resulted in one male carrying 7-and 46-bp deletions in Prkdc, and one female carrying 227-and 716-bp deletions in Prkdc and a 3-bp deletion in Il2rg ( Figure 1B) .
To clarify whether the ZFNs only induced mutations in the targeted region, we checked 12 sites that showed a high rate of similarity to the targeted site at the sequence level with no more than 7-8 bp mismatches, as illustrated in Table S1 . Insertions or deletions were not observed at any of these off-target sites among the ZFN-modified founders. Although we cannot exclude the possibility that the ZFNs cleaved unknown off-target sites, we subsequently excluded such undesired mutations excluded from the genome of the carrier animals by backcrossing to the parental strain. After crossing with wild-type (WT) animals, the ZFN-induced Prkdc and Il2rg mutations were faithfully transmitted through the germline. Some of the ZFN-modified founders were subsequently bred to homozygosity for use in further experiments. (Figure 2A ). When the embryos from Prkdc +/À 3 Prkdc +/À crosses were examined and weighed, a difference in size was observed at embryonic day 14.5 (E14.5), which became statistically significant at E17.5 ( Figure 2B ). During the 6 month observation period, the Prkdc À/À rats grew and maintained a body weight that was 70% of that of the controls ( Figure 2C ). Prkdc À/À SCID rats normally survive for at least 1 year under specific pathogen-free conditions. Both male and female Prkdc À/À rats were fertile, but the average litter size was small (4.7 ± 2.0 [n = 9] versus 9.1 ± 1.6 of F344 rats [n = 12] ). Newly generated F344-Prkdc À/À Il2rg À/À rats (FSG rats) showed phenotypes similar to those of SCID rats for growth, survival, and reproducibility ( Figure 2C ). To further characterize the growth deficiency, we derived primary fibroblasts from WT (+/+), heterozygous (+/À), and homozygous (À/À) rat embryos (rat embryonic fibroblasts [REFs] ), and monitored their growth in vitro ( Figure 2D Figure 2G ). To the best of our knowledge, neither growth retardation nor premature senescence has been reported in SCID mice (Bosma et al., 1983; Gao et al., 1998; Jhappan et al., 1997; Taccioli et al., 1998 Figure 2I ). We next used a pEJ assay (Kobayashi et al., 2010 ) and a DR-GFP (Pierce and Jasin, 2005) assay to further examine the effects of Prkdc-deficiency on the NHEJ and homologous recombination (HR) pathways, respectively. After the generation of DSBs using I-SecI, the number of GFP-positive Prkdc À/À REFs in the pEJ assay significantly decreased compared with that of Prkdc +/+ REFs ( Figure 2J ), clearly indicating a severe deficiency in the NHEJ pathway in these cells. In contrast, the HR pathway was significantly increased in Prkdc
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REFs ( Figure 2K ), suggesting that a deficiency in the NHEJ pathway induces a more active HR pathway as a compensatory mechanism.
Impaired Lymphoid Development in SCID Rats
Gross and microscopic analyses of SCID and FSG rats revealed abnormal lymphoid development ( Figures 3A-3D ). The thymuses from SCID and FSG rats were extremely hypoplastic ( Figure 3A ) and comprised an epithelial rudiment without any lymphocytes ( Figure 3C ). The spleens were also smaller (Figure 3B) , with severely hypoplastic white pulp, and red pulp containing myeloid cells ( Figure 3D ). Serum immunoglobulin (Ig) levels (IgA and IgM) were undetectable in 5-week-old Prkdc À/À rats, whereas IgG levels in Prkdc À/À rats nursed by Prkdc +/À heterozygous mothers were detected at half the levels seen in control Prkdc +/+ rats ( Figures 3E-3G ), confirming the postnatal transfer of maternal IgG previously described in rodents (Gustafsson et al., 1994) . IgG levels were lowest in 8-week-old Prkdc À/À rats, and undetectable in 5-week-old Prkdc À/À rats nursed by Prkdc À/À homozygous mothers ( Figure 3E ). Approximately 20% of young adult (or of the majority of old SCID) mice known to have a ''leaky'' phenotype showed detectable Ig levels, generated by a few clones of functional B cells (Bosma et al., 1983) . To date, none of the SCID rats examined (n = 9, until 1 year of age) have shown a leaky phenotype for serum Ig ( Figures 3E-3G ). Consistent with the histology, the number of thymocytes and splenocytes was markedly reduced in SCID and FSG rats compared with control F344 rats (Table S2 ). In the peripheral blood (PB) profile, the number of white blood cells (WBCs) was reduced in SCID and FSG rats compared with F344 rats (Table S3 ). Differential counts of WBCs showed a dramatic decrease in leucocytes and relative increases in neutrophils and monocytes in SCID and FSG rats (Table S4) .
To further characterize the immunological deficiency in SCID rats, we examined cell populations isolated from the thymus, spleen, and bone marrow (BM) using flow cytometry ( Figures  3H-3J ). CD4 + or CD8 + single-positive (SP), and CD4 + CD8 + double-positive (DP) T cells were completely absent from SCID thymuses but were abundant in control thymuses ( Figure 3H ). This was clearly different from SCID mice, in which DP T cells are present in the thymus (Gao et al., 1998; Taccioli et al., 1998) . CD3 À CD45RA + B cells were completely absent from SCID spleens and BM, whereas CD3 À CD161a + natural killer (NK) cells were present or even increased (Figures 3I and 3J) . NK cell numbers were mostly depleted in the BM and spleens of 5-week-old FSG rats ( Figures 3I and 3J ). Xenotransplantation of Human Induced Pluripotent Stem Cells and Tumor Cells SCID mice can accept transplanted tissues from other species, including humans. We used SCID rats in a teratoma formation (D) Histological analysis of the spleen (3100). In the spleens of SCID and FSG rats, the white pulp was virtually devoid of lymphocytes and the red pulp was occupied by a variety of myeloid cells.
(E-G) ELISA for serum IgG (E), IgA (F), and IgM (G) levels in Prkdc SCID (+/+, n = 3; +/À, n = 6; À/À, n = 4) rats. Error bars indicate the mean ± SEM. IgG, IgA, and IgM levels were very low or undetectable in 5-week-old Prkdc À/À rats nursed by
whereas IgG was detected in 5-week-old Prkdc
rats nursed by a Prkdc +/À heterozygous mother (M: +/À, n = 4) at half the levels seen in the control rats, probably due to transfer through the maternal milk. IgG, IgA, and IgM levels were undetectable in 8-week-old FSG rats (n = 4) and 6-month-old Prkdc À/À rats (+/+, n = 6; À/À, n = 5). assay. Teratomas were induced by inoculation of human induced pluripotent stem (iPS) cells beneath the testis capsule (Takahashi et al., 2007) . All SCID (n = 4/4) and FSG (n = 3/3) rats developed tumors, and in most cases, both testes were affected ( Figure 4A ). Histological examination showed that the lesion had displaced the normal testis and contained solid areas of teratoma. All teratomas contained differentiated tissues representing all three germ layers, including columnar epithelium, pseudostratified ciliated epithelium (endoderm), neural rosettes (ectoderm), cartilage, and adipose tissue (mesoderm; Figures 4B-4F ).
To further evaluate the immunological defects, we used SCID and FSG rats as hosts for the xenotransplantation of human ovarian cancer cells (Mashimo et al., 2010) . All SCID rats (n = 6/6) developed tumors within 14 days after injection of ovarian cancer cells, whereas control F344 rats showed no evidence of tumor growth (n = 0/6; Figure 4G ). Of interest, human cancer cells proliferated more rapidly in FSG rats (n = 6/6), presumably due to the lack of NK cell activity in these animals ( Figure 4H ). The tumors were confirmed by histological analysis, and by PCR using primers to amplify the human MHC class II DQB2 region. These observations illustrate the impaired immune system of SCID and FSG rats, and clearly show that these animals will be useful models for cancer and stem cell research.
Transplantation of Human Hepatocytes and hHSCs
The different metabolic enzyme profiles in human and rat livers are a major limitation for toxicology and drug testing. We generated liver-humanized rats by injecting human hepatocytes into the livers of infant FSG rats pretreated with a pyrrolizidine alkaloid (retrorsine) that is toxic to hepatocytes (Figures 4I-4M ). In this study we used FSG rats because they have more immunocompromised states compared with SCID rats, as observed in the tumor cell engraftment. Human albumin (hAlb) was detectable in the blood of all FSG rats (>1 3 10 3 ng/ml, n = 3) 1 week after transplantation ( Figure 4I ). The hAlb levels increased until 6 weeks after transplantation. However, hAlb was not detectable in F344 control rats (n = 4). Small clusters of human cytokeratin 8/18 (hCK8/18)-positive cells were observed in the livers of the transplanted FSG rats, indicating the successful engraftment and repopulation of human hepatocytes at the tissue level ( Figures 4J and 4K) . The human hepatocytes within these colonies were morphologically normal but their cytoplasm appeared to be clear ( Figure 4L ), probably because of the high glycogen content previously reported in liver-humanized mice (Tateno et al., 2004) . The BrdU-positive donor cells within the colonies represented the proliferation of engrafted human hepatocytes in the livers of FSG rats ( Figure 4M ). The engraftment of hHSCs in immunodeficient mice, such as SCID-hu models (Brehm et al., 2010; Denton and García, 2011; McCune et al., 1989; Pearson et al., 2008; Shultz et al., 2007; Wege et al., 2008) , provides an opportunity to study the human immune system in vivo. To test the capability of this feature, we injected human cord blood (hCB) CD34 + cells into 4-weekold FSG rats. During the 3-month monitoring period after transplantation, no human CD45 + cells could be detected in the PB of hHSC-transplanted FSG rats ( Figure S3A ). Neither human CD3+ T cells nor CD19+ B cells were detected in the PB, spleen, or BM ( Figure S3B ). Furthermore, 6 months after transplantation, no human CD45 + cells were detected in FSG rats ( Figure S3C ).
DISCUSSION
In this study, we successfully generated Prkdc-deficient SCID rats by using the ZFN technology. The SCID rats were significantly different from SCID mice, in that they showed growth retardation, defects in fibroblast proliferation, and a more severe immunodeficient phenotype. This suggests that DNA-PKcs have distinct functions in mice and rats. Although few studies have examined spontaneous null mutations in human DNA-PKcs, it has been reported that gene-targeting disruption of human somatic cells results in profound growth retardation, IR sensitivity, and increased genetic instability (Ruis et al., 2008) . The most reasonable explanation for the phenotypic differences between mice and humans is that human cells express 50 times more DNA-PK activity than rodent cells (Finnie et al., 1995) . Our expression analysis of spleen and fibroblast cells showed that humans express many more DNA-PKcs compared with rodents, and rats express three times more compared with mice (Figure S2) . Although DNA-PKcs play a major role in DSB repair (as do other members of the phosphatidylinositol 3-kinaserelated kinase [PIKK] family, including ATM and ATR), their exact role is still not completely understood. There are at least three DSB repair pathways: NHEJ, HR, and the alternative NHEJ pathway (Mahaney et al., 2009; Shrivastav et al., 2008; Zha et al., 2011) . The pathway used for DSB repair seems to differ between species. NHEJ, in which DNA-PKcs play a key role, is considered to be an error-prone pathway, whereas HR (the major process in lower eukaryotes that lack a DNA-PKcs enzyme) is error-free. Considering that much of the genome in higher eukaryotes comprises less-well-conserved noncoding DNA, NHEJ may have evolved along with DNA-PK activity, particularly in higher mammalian species.
Although SCID mice are the most commonly used experimental animal model for xenograft transplantation, the normal NK cell activity observed in these animals contributes to the limited longevity and function of transplanted human cells (Shultz et al., 2007) . Therefore, we additionally generated FSG rats, which show no such NK cell activity. Although both SCID and FSG rats could serve as hosts for xenogeneic cell grafts such as human iPS cells and ovarian cancer cells, the FSG rats showed higher proliferation of human tumor cells than the SCID rats ( Figure 4H ), indicating a more severely immunocompromised state similar to that reported in Prkdc-and Il2rg-deficient mice used for xenotransplantation of human melanoma cells (Quintana et al., 2008) or human blood cells (Ishikawa et al., 2005) . Further transplantation studies using diverse human cancer cells, such as preclinical cancer cells or cancer stem cells, will be interesting and will improve our understanding of severely immunocompromised hosts.
In addition, we engrafted human hepatocytes into the livers of retrorsine-treated FSG rats ( Figure 4I-4M) . hAlb was secreted in the blood of transplanted FSG rats, and clusters of human transplanted hepatocytes were observed in the livers of the FSG rats. Liver-humanized rats have several advantages over mouse models: (1) rats are 10 times larger than mice, providing greater blood volumes and more bile acid, cells, and tissues; (2) pharmacological and toxicological data have been accumulated for rats; and (3) it is easier to perform complex surgical experiments in rats. Liver-humanized rats may also allow large-scale and high-quality proliferation of either WT human hepatocytes or iPS-derived hepatocytes, which is currently a considerable obstacle to the culture of human hepatocytes. Liver-humanized rats would provide a robust platform for in vivo toxicological assays and drug metabolism assays. Although the replacement rate of human hepatocytes in the FSG rats was still lower compared than that previously obtained in liver-humanized mice (Azuma et al., 2007; Strom et al., 2010; Tateno et al., 2004 ) that were genetically modified using either uroplasminogen activator (uPA) transgenes (Tateno et al., 2004) or Fumaryl acetoacetate hydrolase (Fah) knockouts (Strom et al., 2010) , similar genetic alterations in rats will probably also improve the engraftment success in liver-humanized rats.
Despite these successful results for transplantation of human iPS cells, tumor cells, and hepatocytes, the FSG rats rejected transplanted hHSCs ( Figure S3 ). In mice, xenotransplantation in the nonobese diabetic Prkdc scid (NOD.SCID) or NOD.Prkdc scid .Il2rg À/À (NSG or NOG) mouse has become the gold-standard assay for hHSCs, highlighting the importance of the genetic background for such transplantation experiments. Recently, it was shown that the signal regulatory protein alpha (Sirpa) of the NOD allele enhances binding to the human CD47 and could provide inhibitory regulation of mouse phagocytes by CD47-SIRPa interaction (the so-called ''don't eat me'' signal), allowing significantly increased engraftment and maintenance of hHSCs in the mouse BM (Takenaka et al., 2007) . This was also supported by experiments in which transgenic mice with human SIRPa in the non-NOD background showed significantly higher levels of human cell engraftment comparable to those in NSG mice (Strowig et al., 2011) . Transgenic FSG rats with human SIRPa or NOD-SIRPa may change the BM microenvironment of FSG rats in a way that allows them to accept the engraftment of hHSCs. In addition to Sirpa, structural species-specific differences in the BM environment between mice and rats, and differences in the protocols used for HSC engraftment may explain why transplantation of hHSCs fails in FSG rats.
In conclusion, the newly developed SCID and FSG rats described in this study can be a valuable resource in various fields, such as stem cell research and translational research, and serve as an important experimental model for preclinical drug testing. These humanized models will also allow preclinical evaluation of stem-cell-based therapies and expand the options for translational research. This is particularly important in the field of regenerative medicine, because humanized rats can be used to evaluate not only the ability of the cells to engraft but also their therapeutic efficiency. However, additional genetic modifications may be required to permit transplantation of human cells or tissues, such as human hepatocytes and hHSCs.
EXPERIMENTAL PROCEDURES
Generation of Knockout Rats Using ZFNs
Custom-designed ZFN plasmids for the rat Prkdc gene and the Il2rg gene were obtained from Sigma-Aldrich (St. Louis, MO). The design, cloning, and validation of the ZFNs were performed as previously described (Mashimo et al., 2010) . In brief, ZFNs were designed to recognize a site-specific sequence within the first exon of the rat Prkdc gene ( Figure S4 ). Approximately 2-3 pl of ZFN mRNA (10 ng/ml) were injected into the pronuclei of embryos collected from F344/Stm or Crlj:WI females as previously described (Mashimo et al., 2010 ). The cultured embryos were then transferred to the oviducts of pseudopregnant females (Crlj:WI, 8-10 weeks). To edit the ZFN cleavage site in the genome at the Prkdc locus, two primer sets were designed to amplify small (309 bp) and large (1,321 bp) fragments as shown in Figure S4 . The PCR products were directly sequenced using the BigDye terminator v3.1 cycle sequencing mix and the standard protocol for an Applied Biosystems 3130 DNA Sequencer (Carlsbad, CA).
All animal care and experiments conformed to the Guidelines for Animal Experiments of Kyoto University, and were approved by the Animal Research Committee of Kyoto University. Transplantation studies using human hepatocytes were approved by the Ethics Board of PhoenixBio Co., Ltd. (Higashihiroshima, Japan). All SCID rats were maintained under specific pathogen-free conditions. The SCID rats are deposited in the National BioResource Project-Rat in Japan (http://www.anim.med.kyoto-u.ac.jp/nbr).
RT-PCR and Western Blotting
Total RNA was extracted from the spleens of 5-week-old rats using Isogen reagent (Nippon Gene, Tokyo, Japan). RT-PCR was performed using the primers for Prkdc described in Figure S2 , and with Gapdh 5 
Preparation of Immortalized REF Cells
Generation of immortalized REF cells by human telomerase reverse transcriptase (hTERT) was performed as previously described (Nakamura et al., 2002) . Briefly, rat primary fibroblasts (+/+, +/À, or À/À) were infected with an hTERTintroduced retrovirus and then continuously cultured with G418. After a few weeks, viable cells were infected with SV40 and then continuously cultured for >1 month. These transformed cells (REF-hTERT/SV) were used for radiation sensitivity assays, and HR and NHEJ assays.
Radiation Sensitivity Assay and Immunofluorescence Staining for g-H2AX Foci
For the radiation sensitivity assays, the cells were trypsinized and irradiated with 3 or 5 Gy of 60 Co g-rays at a dose rate of 1.1 Gy/min. Immediately after irradiation, the cells were plated into 100 mm dishes at a density such that 50-200 cells would survive, and then incubated for 10 days. The dishes were then fixed with ethanol and stained with 3% Giemsa, and the number of colonies was counted. The surviving fractions were calculated by comparing the number of colonies formed by irradiated cells with the number of colonies formed by nonirradiated control cells. Each result represents an average value from three independent experiments. Immunostaining for g-H2AX foci was performed as previously described (Kobayashi et al., 2010) . Cells grown on a glass slide were fixed with cold methanol for 15 min, rinsed with cold acetone several times, and then air-dried. Anti-g-H2AX antibody (Upstate: #05-636) and Alexa-596-conjugated antimouse IgG antibodies (Molecular Probes, Carlsbad, CA) were to visualize the g-H2AX foci.
NHEJ and HR Assays NHEJ and HR assays were performed as previously described (Kobayashi et al., 2010; Pierce and Jasin, 2005) . The cells were generated from REFhTERT/SV cells via introduction of a pEJ construct for the NHEJ assay or a DR-GFP construct for the HR assay. To measure the repair of I-SceI-generated DSBs, 50 mg of the I-SceI expression vector (pCBASce) was introduced into 1 3 10 6 cells by electroporation (GenePulser; Bio-Rad, Hercules, CA).
To determine the level of NHEJ or HR repair, the percentage of GFP-positive cells was quantified by flow cytometry (FACSCalibur; Becton Dickinson, Franklin Lakes, NJ) 3 days after electroporation.
Immunofluorescence and Fluorescence-Activated Cell-Sorting Analysis PB specimens were collected from the caudal vena cava. Serum Ig levels were measured by ELISA using Rat IgG, IgA, and IgM ELISA quantitation kits (Bethyl Laboratories, Montgomery, TX). For histopathology, tissues were fixed in Bouin's fluid and embedded in paraffin. The embedded tissues were then sectioned (5-7 mm thick) at room temperature and stained with hematoxylin and eosin (H&E) to permit evaluation by light microscopy. Flow cytometric analysis of cell populations isolated from thymus, BM, and spleen were carried out using IOTest Anti-Rat CD3-FITC/CD45RA-PC7/ CD161a-APC (Beckman Coulter, Fullerton, CA) to differentiate the T cell, B cell, and NK cell subpopulations, and IOTest Anti-Rat CD3-FITC/CD4-PC7/ CD8-APC (Beckman Coulter) to enumerate the T cell subpopulations. Anti-CD45 monoclonal antibodies (Beckman Coulter) were used for the intracellular staining of lymphocytes. Mouse IgM, IgG1, and IgG2a antibodies (Beckman Coulter) were used as isotype-matched controls. The cell samples were treated with FcR-blocking reagent (Miltenyi Biotec, Auburn, CA) for 10 min, stained with the fluorochrome-conjugated antibodies for 30 min, and washed three times with PBS/10% FCS. Stained cell samples were analyzed with the use of a four-color fluorescence-activated cell-sorting (FACS) flow cytometer (FACSCalibur; Becton Dickinson) and the data were analyzed with CellQuest software (Becton Dickinson).
Teratoma Formation by Human iPS Cells
Human iPS cells (201B7) were supplied by the Center for iPS Cell Research and Application, Kyoto University (Kyoto, Japan). Clumps of $2 3 10 5 human iPS cells with an undifferentiated morphology were harvested at the time of routine passage as described previously (Takahashi et al., 2007) , and injected into the testis of 6-to 8-week-old rats. Six to 8 weeks later, when testicular lesions developed and were palpable, the resulting tumors were dissected, fixed in 10% neutral buffered formalin, embedded in paraffin, and examined histologically after H&E staining.
Tumor Cell Xenotransplantation
The human ovarian cancer cell line A2780 was purchased from the European Collection of Cell Cultures (ECACC, Wiltshire, UK). Cells were cultured in RPMI 1640 medium (GIBCO, Fort Worth, TX) with 10% heat-inactivated FBS (Hyclone, Logan, UT). Subcutaneous injections of 2 3 10 5 A2780 cells plus Matrigel (Becton Dickinson) were performed on 5-week-old female rats. Tumors were measured (length [a] and width [b] ) in millimeters using calipers, and tumor volumes (V) were calculated using the formula V = ab 2 /2, where a is the longer of the two measurements. Human-specific PCR primers were designed to amplify major histocompatibility complex class II DQ beta 2 (HLA-DQB2) at exon 4 as follows: 5 0 -CCTAGGGTGGTCAGACTGGA-3 0 and 5 0 -AAAATCCCCCAAAACAAAGG-3 0 .
Transplantation of Human Hepatocytes
Human hepatocytes were isolated from human-hepatocyte chimeric mice (PXB mice, http://www.phoenixbio.co.jp) using the two-step collagenase perfusion method as described previously (Yamasaki et al., 2010) . The donor cells (cryopreserved human hepatocytes derived from a 5-year-old boy) were purchased from BD Gentest (Becton Dickinson). Two-week-old rats were given intraperitoneal injections of retrorsine (Sigma-Aldrich) at 10 mg/kg body weight. Seven days after retrorsine treatment, the isolated human hepatocytes (5 or 10 3 10 5 viable cells) were transplanted into the animals via the portal vein. To deplete Kupffer cells, the rats were injected intraperitoneally with 10 ml/kg of liposome-encapsulated clodronate 2 days before and 3 days after transplantation. Plasma samples were collected weekly and hAlb levels were measured by ELISA (Human Serum Albumin ELISA Quantitation Kit; Bethyl Laboratories). The rat livers were harvested 6 weeks after transplantation. When necessary, BrdU (50 mg/kg; Sigma-Aldrich) was injected intraperitoneally 1 hr before sacrifice. Paraffin and frozen sections (5 mm thick) were prepared from the liver tissues and subjected to H&E or immunohistochemical staining using human-specific hCK8/18 mouse monoclonal antibodies (NCL5D3; MP Biomedicals, Aurora, OH) or BrdU mouse monoclonal antibodies (Bu20a; Dako Cytomation, Glostrup, Denmark). The antibodies were visualized with a Vectastain ABC Kit (Vector Laboratories, Burlingame, CA) using DAB substrates. 
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